HSBC Holdings on Thursday, January 18, agreed to pay US$101.5 million to settle a US criminal probe into the rigging of currency transactions, which has already led the conviction of one of its former bankers.
The payment includes a US$63.1 million fine plus US$38.4 million in restitution to a corporate client, according to a deferred prosecution agreement filed on Thursday with the US District Court in Brooklyn, New York.
In the settlement with the US Department of Justice, HSBC also agreed to bolster its internal controls, and admitted and accepted responsibility for wrongdoing underlying two criminal wire fraud charges filed on Thursday against the bank, according to the agreement.
Deferred prosecution agreements let companies avoid criminal charges so long as they comply with the terms.
Thursday’s sanctions came a month after HSBC was freed from a five-year deferred prosecution agreement over its alleged dealings with Mexican drug cartels and other money launderers, and conducting of transactions for customers in countries barred by US sanctions. It was fined US$1.92 billion in that case.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas